science
Sciencedaily
2026-09-17
Experimental Mesothelioma Drug Shows Promise by Targeting Tumor Antioxidant Defenses
A new experimental drug is showing success against aggressive mesothelioma by disabling a key antioxidant defense mechanism in cancer cells. Early clinical trials indicate high rates of disease control in patients.